Recombinant IL5RA (Benralizumab Biosimilar) antibody

Catalog No. ABIN7487950

This anti-IL5RA (Benralizumab Biosimilar) antibody is a Mammalian Cells Monoclonal antibody detecting IL5RA (Benralizumab Biosimilar) in ELISA. Suitable for Human.

Quick Overview for Recombinant IL5RA (Benralizumab Biosimilar) antibody (ABIN7487950)

Target: IL5RA (Benralizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This IL5RA (Benralizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-IL5RA (Benralizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Benralizumab Biosimilar - Anti-IL5RA, CD125 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for IL5RA (Benralizumab Biosimilar)

Target: IL5RA (Benralizumab Biosimilar)

Target Type: Biosimilar

Background: BIW-8405,KHK4563,MEDI-563
Benralizumab is a monoclonal antibody medication which is developed for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).

CAS-No: 1044511-01-4